Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Raymond James to hold a virtual conference » 04:55
03/03/21
03/03
04:55
03/03/21
04:55
JLL

Jones Lang LaSalle

$178.34 /

-0.7 (-0.39%)

, PODD

Insulet

$266.20 /

-4.54 (-1.68%)

, SMG

Scotts Miracle-Gro

$216.58 /

-8.37 (-3.72%)

, IDXX

Idexx Laboratories

$529.63 /

-7.96 (-1.48%)

, APLS

Apellis

$45.60 /

-2.13 (-4.46%)

, AVT

Avnet

$38.79 /

-0.62 (-1.57%)

, SBAC

SBA Communications

$246.29 /

-1.45 (-0.59%)

, LPTX

Leap Therapeutics

$2.36 /

-0.06 (-2.48%)

, RJF

Raymond James

$118.27 /

-2.71 (-2.24%)

, WY

Weyerhaeuser

$33.80 /

-1.26 (-3.59%)

, LZB

La-Z-Boy

$41.30 /

-0.7 (-1.67%)

, DXCM

DexCom

$391.96 /

-4.42 (-1.12%)

, ADMA

ADMA Biologics

$2.36 /

-0.045 (-1.87%)

, CTT

CatchMark Timber

$10.51 /

-0.08 (-0.76%)

, CACI

CACI

$219.02 /

-8.08 (-3.56%)

, BR

Broadridge

$143.68 /

-2.765 (-1.89%)

, CWST

Casella Waste

$61.15 /

+0.6 (+0.99%)

, FLXN

Flexion

$11.09 /

-0.32 (-2.80%)

, HOLX

Hologic

$74.81 /

+0.2 (+0.27%)

, VSAT

ViaSat

$52.77 /

-0.08 (-0.15%)

42nd Annual Institutional…

42nd Annual Institutional Investors Virtual Conference will be held on March 1-3.

ShowHide Related Items >><<
WY Weyerhaeuser
$33.80 /

-1.26 (-3.59%)

VSAT ViaSat
$52.77 /

-0.08 (-0.15%)

SMG Scotts Miracle-Gro
$216.58 /

-8.37 (-3.72%)

SBAC SBA Communications
$246.29 /

-1.45 (-0.59%)

RJF Raymond James
$118.27 /

-2.71 (-2.24%)

PODD Insulet
$266.20 /

-4.54 (-1.68%)

LZB La-Z-Boy
$41.30 /

-0.7 (-1.67%)

LPTX Leap Therapeutics
$2.36 /

-0.06 (-2.48%)

JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

IDXX Idexx Laboratories
$529.63 /

-7.96 (-1.48%)

HOLX Hologic
$74.81 /

+0.2 (+0.27%)

FLXN Flexion
$11.09 /

-0.32 (-2.80%)

DXCM DexCom
$391.96 /

-4.42 (-1.12%)

CWST Casella Waste
$61.15 /

+0.6 (+0.99%)

CACI CACI
$219.02 /

-8.08 (-3.56%)

BR Broadridge
$143.68 /

-2.765 (-1.89%)

AVT Avnet
$38.79 /

-0.62 (-1.57%)

APLS Apellis
$45.60 /

-2.13 (-4.46%)

ADMA ADMA Biologics
$2.36 /

-0.045 (-1.87%)

JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
PODD Insulet
$266.20 /

-4.54 (-1.68%)

02/25/21 Oppenheimer
Insulet price target raised to $277 from $235 at Oppenheimer
02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
SMG Scotts Miracle-Gro
$216.58 /

-8.37 (-3.72%)

02/04/21 Truist
Scotts Miracle-Gro price target raised to $270 from $250 at Truist
01/11/21 Raymond James
Scotts Miracle-Gro price target raised to $274 from $224 at Raymond James
01/07/21 Truist
Scotts Miracle-Gro price target raised to $250 from $180 at Truist
12/11/20
Fly Intel: Top five analyst upgrades
IDXX Idexx Laboratories
$529.63 /

-7.96 (-1.48%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
APLS Apellis
$45.60 /

-2.13 (-4.46%)

01/29/21 Baird
Apellis assumed at Outperform at Baird
12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
AVT Avnet
$38.79 /

-0.62 (-1.57%)

02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
01/29/21 Loop Capital
Avnet price target raised to $39 from $32 at Loop Capital
01/19/21 Citi
Citi boosts Avnet target to $40, opens 'Positive Catalyst Watch'
12/14/20 Goldman Sachs
Avnet price target raised to $25 from $23 at Goldman Sachs
SBAC SBA Communications
$246.29 /

-1.45 (-0.59%)

02/23/21 Credit Suisse
SBA Communications price target lowered to $277 from $291 at Credit Suisse
02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
LPTX Leap Therapeutics
$2.36 /

-0.06 (-2.48%)

01/29/21 Baird
Leap Therapeutics assumed at Outperform at Baird
06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
RJF Raymond James
$118.27 /

-2.71 (-2.24%)

01/29/21 Citi
Citi opens 'Positive Catalyst Watch' on Raymond James, ups price target
01/15/21 Wells Fargo
Raymond James double upgraded to Overweight at Wells Fargo
01/15/21 Wells Fargo
Raymond James upgraded to Overweight from Underweight at Wells Fargo
01/05/21 Wolfe Research
Raymond James upgraded to Outperform from Peer Perform at Wolfe Research
WY Weyerhaeuser
$33.80 /

-1.26 (-3.59%)

02/01/21 DA Davidson
Weyerhaeuser price target raised to $34 from $29 at DA Davidson
12/04/20 Raymond James
Weyerhaeuser upgraded to Outperform from Market Perform at Raymond James
08/03/20
Fly Intel: Top five analyst downgrades
08/03/20 DA Davidson
Weyerhaeuser downgraded to Neutral from Buy at DA Davidson
LZB La-Z-Boy
$41.30 /

-0.7 (-1.67%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
04/13/20 Sidoti
La-Z-Boy downgraded to Neutral from Buy at Sidoti
DXCM DexCom
$391.96 /

-4.42 (-1.12%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
ADMA ADMA Biologics
$2.36 /

-0.045 (-1.87%)

10/01/20 Raymond James
ADMA Biologics price target raised to $9 from $7 at Raymond James
09/30/20 Jefferies
ADMA Biologics shares 'in arbitrage territory,' says Jefferies
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
CTT CatchMark Timber
$10.51 /

-0.08 (-0.76%)

02/16/21 B. Riley Securities
CatchMark Timber price target raised to $12.50 from $11 at B. Riley
02/12/21 RBC Capital
CatchMark Timber cut to Sector Perform at RBC Capital on more limited growth
02/12/21 RBC Capital
CatchMark Timber downgraded to Sector Perform from Outperform at RBC Capital
10/30/20 RBC Capital
CatchMark Timber upgraded to Outperform from Sector Perform at RBC Capital
CACI CACI
$219.02 /

-8.08 (-3.56%)

02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
09/22/20 JPMorgan
JPMorgan upgrades 'relatively resilient' CACI to Overweight
BR Broadridge
$143.68 /

-2.765 (-1.89%)

02/03/21 BTIG
Broadridge upgraded to Buy from Neutral at BTIG
12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
CWST Casella Waste
$61.15 /

+0.6 (+0.99%)

12/21/20
Fly Intel: Top five analyst initiations
12/21/20 BofA
Casella Waste initiated with a Neutral at BofA
10/15/20 Berenberg
Casella Waste initiated with a Buy at Berenberg
09/24/20 Stifel
Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth
FLXN Flexion
$11.09 /

-0.32 (-2.80%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
HOLX Hologic
$74.81 /

+0.2 (+0.27%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
VSAT ViaSat
$52.77 /

-0.08 (-0.15%)

02/12/21 Barclays
ViaSat price target raised to $65 from $53 at Barclays
02/05/21 William Blair
William Blair upgrades ViaSat, sees upside to $90-$110 per share
02/05/21 William Blair
ViaSat upgraded to Outperform from Market Perform at William Blair
01/07/21 William Blair
ViaSat win at Delta likely brings large upfront cost, says William Blair
WY Weyerhaeuser
$33.80 /

-1.26 (-3.59%)

VSAT ViaSat
$52.77 /

-0.08 (-0.15%)

SMG Scotts Miracle-Gro
$216.58 /

-8.37 (-3.72%)

SBAC SBA Communications
$246.29 /

-1.45 (-0.59%)

RJF Raymond James
$118.27 /

-2.71 (-2.24%)

PODD Insulet
$266.20 /

-4.54 (-1.68%)

LZB La-Z-Boy
$41.30 /

-0.7 (-1.67%)

LPTX Leap Therapeutics
$2.36 /

-0.06 (-2.48%)

JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

IDXX Idexx Laboratories
$529.63 /

-7.96 (-1.48%)

HOLX Hologic
$74.81 /

+0.2 (+0.27%)

FLXN Flexion
$11.09 /

-0.32 (-2.80%)

DXCM DexCom
$391.96 /

-4.42 (-1.12%)

CWST Casella Waste
$61.15 /

+0.6 (+0.99%)

CTT CatchMark Timber
$10.51 /

-0.08 (-0.76%)

CACI CACI
$219.02 /

-8.08 (-3.56%)

BR Broadridge
$143.68 /

-2.765 (-1.89%)

AVT Avnet
$38.79 /

-0.62 (-1.57%)

APLS Apellis
$45.60 /

-2.13 (-4.46%)

ADMA ADMA Biologics
$2.36 /

-0.045 (-1.87%)

  • 21
    Oct
  • 18
    Jun
  • 21
    May
  • 13
    May
SMG Scotts Miracle-Gro
$216.58 /

-8.37 (-3.72%)

SBAC SBA Communications
$246.29 /

-1.45 (-0.59%)

RJF Raymond James
$118.27 /

-2.71 (-2.24%)

HOLX Hologic
$74.81 /

+0.2 (+0.27%)

VSAT ViaSat
$52.77 /

-0.08 (-0.15%)

SMG Scotts Miracle-Gro
$216.58 /

-8.37 (-3.72%)

LZB La-Z-Boy
$41.30 /

-0.7 (-1.67%)

HOLX Hologic
$74.81 /

+0.2 (+0.27%)

DXCM DexCom
$391.96 /

-4.42 (-1.12%)

CWST Casella Waste
$61.15 /

+0.6 (+0.99%)

APLS Apellis
$45.60 /

-2.13 (-4.46%)

WY Weyerhaeuser
$33.80 /

-1.26 (-3.59%)

IDXX Idexx Laboratories
$529.63 /

-7.96 (-1.48%)

HOLX Hologic
$74.81 /

+0.2 (+0.27%)

ADMA ADMA Biologics
$2.36 /

-0.045 (-1.87%)

Tuesday
Conference/Events
Raymond James to hold a virtual conference » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
JLL

Jones Lang LaSalle

$179.05 /

+4.565 (+2.62%)

, PODD

Insulet

$270.70 /

+10.41 (+4.00%)

, SMG

Scotts Miracle-Gro

$224.83 /

+11.37 (+5.33%)

, IDXX

Idexx Laboratories

$538.76 /

+18.79 (+3.61%)

, APLS

Apellis

$47.66 /

-0.66 (-1.37%)

, AVT

Avnet

$39.47 /

+1.325 (+3.47%)

, SBAC

SBA Communications

$248.08 /

-7.18 (-2.81%)

, LPTX

Leap Therapeutics

$2.42 /

+0.06 (+2.54%)

, RJF

Raymond James

$120.98 /

+4.28 (+3.67%)

, WY

Weyerhaeuser

$35.06 /

+1.18 (+3.48%)

, LZB

La-Z-Boy

$42.00 /

-0.74 (-1.73%)

, DXCM

DexCom

$397.08 /

-2.17 (-0.54%)

, ADMA

ADMA Biologics

$2.41 /

+0.095 (+4.11%)

, CTT

CatchMark Timber

$10.59 /

+0.39 (+3.82%)

, CACI

CACI

$226.70 /

+5.55 (+2.51%)

, BR

Broadridge

$146.44 /

+3.88 (+2.72%)

, CWST

Casella Waste

$60.56 /

+2.42 (+4.16%)

, FLXN

Flexion

$11.41 /

+0.36 (+3.26%)

, HOLX

Hologic

$74.61 /

+2.46 (+3.41%)

, VSAT

ViaSat

$52.85 /

+1.34 (+2.60%)

42nd Annual Institutional…

42nd Annual Institutional Investors Virtual Conference will be held on March 1-3.

ShowHide Related Items >><<
WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

PODD Insulet
$270.70 /

+10.41 (+4.00%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

FLXN Flexion
$11.41 /

+0.36 (+3.26%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

CACI CACI
$226.70 /

+5.55 (+2.51%)

BR Broadridge
$146.44 /

+3.88 (+2.72%)

AVT Avnet
$39.47 /

+1.325 (+3.47%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
PODD Insulet
$270.70 /

+10.41 (+4.00%)

02/25/21 Oppenheimer
Insulet price target raised to $277 from $235 at Oppenheimer
02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

02/04/21 Truist
Scotts Miracle-Gro price target raised to $270 from $250 at Truist
01/11/21 Raymond James
Scotts Miracle-Gro price target raised to $274 from $224 at Raymond James
01/07/21 Truist
Scotts Miracle-Gro price target raised to $250 from $180 at Truist
12/11/20
Fly Intel: Top five analyst upgrades
IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
APLS Apellis
$47.66 /

-0.66 (-1.37%)

01/29/21 Baird
Apellis assumed at Outperform at Baird
12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
AVT Avnet
$39.47 /

+1.325 (+3.47%)

02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
01/29/21 Loop Capital
Avnet price target raised to $39 from $32 at Loop Capital
01/19/21 Citi
Citi boosts Avnet target to $40, opens 'Positive Catalyst Watch'
12/14/20 Goldman Sachs
Avnet price target raised to $25 from $23 at Goldman Sachs
SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

02/23/21 Credit Suisse
SBA Communications price target lowered to $277 from $291 at Credit Suisse
02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

01/29/21 Baird
Leap Therapeutics assumed at Outperform at Baird
06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
RJF Raymond James
$120.98 /

+4.28 (+3.67%)

01/29/21 Citi
Citi opens 'Positive Catalyst Watch' on Raymond James, ups price target
01/15/21 Wells Fargo
Raymond James double upgraded to Overweight at Wells Fargo
01/15/21 Wells Fargo
Raymond James upgraded to Overweight from Underweight at Wells Fargo
01/05/21 Wolfe Research
Raymond James upgraded to Outperform from Peer Perform at Wolfe Research
WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

02/01/21 DA Davidson
Weyerhaeuser price target raised to $34 from $29 at DA Davidson
12/04/20 Raymond James
Weyerhaeuser upgraded to Outperform from Market Perform at Raymond James
08/03/20
Fly Intel: Top five analyst downgrades
08/03/20 DA Davidson
Weyerhaeuser downgraded to Neutral from Buy at DA Davidson
LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
04/13/20 Sidoti
La-Z-Boy downgraded to Neutral from Buy at Sidoti
DXCM DexCom
$397.08 /

-2.17 (-0.54%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

10/01/20 Raymond James
ADMA Biologics price target raised to $9 from $7 at Raymond James
09/30/20 Jefferies
ADMA Biologics shares 'in arbitrage territory,' says Jefferies
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
CTT CatchMark Timber
$10.59 /

+0.39 (+3.82%)

02/16/21 B. Riley Securities
CatchMark Timber price target raised to $12.50 from $11 at B. Riley
02/12/21 RBC Capital
CatchMark Timber cut to Sector Perform at RBC Capital on more limited growth
02/12/21 RBC Capital
CatchMark Timber downgraded to Sector Perform from Outperform at RBC Capital
10/30/20 RBC Capital
CatchMark Timber upgraded to Outperform from Sector Perform at RBC Capital
CACI CACI
$226.70 /

+5.55 (+2.51%)

02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
09/22/20 JPMorgan
JPMorgan upgrades 'relatively resilient' CACI to Overweight
BR Broadridge
$146.44 /

+3.88 (+2.72%)

02/03/21 BTIG
Broadridge upgraded to Buy from Neutral at BTIG
12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

12/21/20
Fly Intel: Top five analyst initiations
12/21/20 BofA
Casella Waste initiated with a Neutral at BofA
10/15/20 Berenberg
Casella Waste initiated with a Buy at Berenberg
09/24/20 Stifel
Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth
FLXN Flexion
$11.41 /

+0.36 (+3.26%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
HOLX Hologic
$74.61 /

+2.46 (+3.41%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

02/12/21 Barclays
ViaSat price target raised to $65 from $53 at Barclays
02/05/21 William Blair
William Blair upgrades ViaSat, sees upside to $90-$110 per share
02/05/21 William Blair
ViaSat upgraded to Outperform from Market Perform at William Blair
01/07/21 William Blair
ViaSat win at Delta likely brings large upfront cost, says William Blair
WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

PODD Insulet
$270.70 /

+10.41 (+4.00%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

FLXN Flexion
$11.41 /

+0.36 (+3.26%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

CTT CatchMark Timber
$10.59 /

+0.39 (+3.82%)

CACI CACI
$226.70 /

+5.55 (+2.51%)

BR Broadridge
$146.44 /

+3.88 (+2.72%)

AVT Avnet
$39.47 /

+1.325 (+3.47%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

  • 21
    Oct
  • 18
    Jun
  • 21
    May
  • 13
    May
SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

Monday
Conference/Events
Raymond James to hold a virtual conference » 10:00
03/01/21
03/01
10:00
03/01/21
10:00
JLL

Jones Lang LaSalle

$178.94 /

+4.46 (+2.56%)

, PODD

Insulet

$264.49 /

+4.2 (+1.61%)

, SMG

Scotts Miracle-Gro

$216.66 /

+3.2 (+1.50%)

, IDXX

Idexx Laboratories

$527.46 /

+7.49 (+1.44%)

, APLS

Apellis

$49.34 /

+1.02 (+2.11%)

, AVT

Avnet

$38.99 /

+0.85 (+2.23%)

, SBAC

SBA Communications

$254.95 /

-0.31 (-0.12%)

, LPTX

Leap Therapeutics

$2.45 /

+0.09 (+3.81%)

, RJF

Raymond James

$120.08 /

+3.38 (+2.90%)

, WY

Weyerhaeuser

$34.81 /

+0.93 (+2.74%)

, LZB

La-Z-Boy

$42.83 /

+0.09 (+0.21%)

, DXCM

DexCom

$401.50 /

+2.25 (+0.56%)

, ADMA

ADMA Biologics

$2.38 /

+0.07 (+3.03%)

, CTT

CatchMark Timber

$10.45 /

+0.25 (+2.45%)

, CACI

CACI

$223.64 /

+2.49 (+1.13%)

, BR

Broadridge

$144.31 /

+1.75 (+1.23%)

, CWST

Casella Waste

$58.82 /

+0.68 (+1.17%)

, FLXN

Flexion

$11.48 /

+0.43 (+3.89%)

, HOLX

Hologic

$74.58 /

+2.43 (+3.37%)

, VSAT

ViaSat

$52.50 /

+0.99 (+1.92%)

42nd Annual Institutional…

42nd Annual Institutional Investors Virtual Conference will be held on March 1-3.

ShowHide Related Items >><<
WY Weyerhaeuser
$34.81 /

+0.93 (+2.74%)

VSAT ViaSat
$52.50 /

+0.99 (+1.92%)

SMG Scotts Miracle-Gro
$216.66 /

+3.2 (+1.50%)

SBAC SBA Communications
$254.95 /

-0.31 (-0.12%)

RJF Raymond James
$120.08 /

+3.38 (+2.90%)

PODD Insulet
$264.49 /

+4.2 (+1.61%)

LZB La-Z-Boy
$42.83 /

+0.09 (+0.21%)

LPTX Leap Therapeutics
$2.45 /

+0.09 (+3.81%)

JLL Jones Lang LaSalle
$178.94 /

+4.46 (+2.56%)

IDXX Idexx Laboratories
$527.46 /

+7.49 (+1.44%)

HOLX Hologic
$74.58 /

+2.43 (+3.37%)

FLXN Flexion
$11.48 /

+0.43 (+3.89%)

DXCM DexCom
$401.50 /

+2.25 (+0.56%)

CWST Casella Waste
$58.82 /

+0.68 (+1.17%)

CACI CACI
$223.64 /

+2.49 (+1.13%)

BR Broadridge
$144.31 /

+1.75 (+1.23%)

AVT Avnet
$38.99 /

+0.85 (+2.23%)

APLS Apellis
$49.34 /

+1.02 (+2.11%)

ADMA ADMA Biologics
$2.38 /

+0.07 (+3.03%)

JLL Jones Lang LaSalle
$178.94 /

+4.46 (+2.56%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
PODD Insulet
$264.49 /

+4.2 (+1.61%)

02/25/21 Oppenheimer
Insulet price target raised to $277 from $235 at Oppenheimer
02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
SMG Scotts Miracle-Gro
$216.66 /

+3.2 (+1.50%)

02/04/21 Truist
Scotts Miracle-Gro price target raised to $270 from $250 at Truist
01/11/21 Raymond James
Scotts Miracle-Gro price target raised to $274 from $224 at Raymond James
01/07/21 Truist
Scotts Miracle-Gro price target raised to $250 from $180 at Truist
12/11/20
Fly Intel: Top five analyst upgrades
IDXX Idexx Laboratories
$527.46 /

+7.49 (+1.44%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
APLS Apellis
$49.34 /

+1.02 (+2.11%)

01/29/21 Baird
Apellis assumed at Outperform at Baird
12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
AVT Avnet
$38.99 /

+0.85 (+2.23%)

02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
01/29/21 Loop Capital
Avnet price target raised to $39 from $32 at Loop Capital
01/19/21 Citi
Citi boosts Avnet target to $40, opens 'Positive Catalyst Watch'
12/14/20 Goldman Sachs
Avnet price target raised to $25 from $23 at Goldman Sachs
SBAC SBA Communications
$254.95 /

-0.31 (-0.12%)

02/23/21 Credit Suisse
SBA Communications price target lowered to $277 from $291 at Credit Suisse
02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
LPTX Leap Therapeutics
$2.45 /

+0.09 (+3.81%)

01/29/21 Baird
Leap Therapeutics assumed at Outperform at Baird
06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
RJF Raymond James
$120.08 /

+3.38 (+2.90%)

01/29/21 Citi
Citi opens 'Positive Catalyst Watch' on Raymond James, ups price target
01/15/21 Wells Fargo
Raymond James double upgraded to Overweight at Wells Fargo
01/15/21 Wells Fargo
Raymond James upgraded to Overweight from Underweight at Wells Fargo
01/05/21 Wolfe Research
Raymond James upgraded to Outperform from Peer Perform at Wolfe Research
WY Weyerhaeuser
$34.81 /

+0.93 (+2.74%)

02/01/21 DA Davidson
Weyerhaeuser price target raised to $34 from $29 at DA Davidson
12/04/20 Raymond James
Weyerhaeuser upgraded to Outperform from Market Perform at Raymond James
08/03/20
Fly Intel: Top five analyst downgrades
08/03/20 DA Davidson
Weyerhaeuser downgraded to Neutral from Buy at DA Davidson
LZB La-Z-Boy
$42.83 /

+0.09 (+0.21%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
04/13/20 Sidoti
La-Z-Boy downgraded to Neutral from Buy at Sidoti
DXCM DexCom
$401.50 /

+2.25 (+0.56%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
ADMA ADMA Biologics
$2.38 /

+0.07 (+3.03%)

10/01/20 Raymond James
ADMA Biologics price target raised to $9 from $7 at Raymond James
09/30/20 Jefferies
ADMA Biologics shares 'in arbitrage territory,' says Jefferies
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
CTT CatchMark Timber
$10.45 /

+0.25 (+2.45%)

02/16/21 B. Riley Securities
CatchMark Timber price target raised to $12.50 from $11 at B. Riley
02/12/21 RBC Capital
CatchMark Timber cut to Sector Perform at RBC Capital on more limited growth
02/12/21 RBC Capital
CatchMark Timber downgraded to Sector Perform from Outperform at RBC Capital
10/30/20 RBC Capital
CatchMark Timber upgraded to Outperform from Sector Perform at RBC Capital
CACI CACI
$223.64 /

+2.49 (+1.13%)

02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
09/22/20 JPMorgan
JPMorgan upgrades 'relatively resilient' CACI to Overweight
BR Broadridge
$144.31 /

+1.75 (+1.23%)

02/03/21 BTIG
Broadridge upgraded to Buy from Neutral at BTIG
12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
CWST Casella Waste
$58.82 /

+0.68 (+1.17%)

12/21/20
Fly Intel: Top five analyst initiations
12/21/20 BofA
Casella Waste initiated with a Neutral at BofA
10/15/20 Berenberg
Casella Waste initiated with a Buy at Berenberg
09/24/20 Stifel
Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth
FLXN Flexion
$11.48 /

+0.43 (+3.89%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
HOLX Hologic
$74.58 /

+2.43 (+3.37%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
VSAT ViaSat
$52.50 /

+0.99 (+1.92%)

02/12/21 Barclays
ViaSat price target raised to $65 from $53 at Barclays
02/05/21 William Blair
William Blair upgrades ViaSat, sees upside to $90-$110 per share
02/05/21 William Blair
ViaSat upgraded to Outperform from Market Perform at William Blair
01/07/21 William Blair
ViaSat win at Delta likely brings large upfront cost, says William Blair
WY Weyerhaeuser
$34.81 /

+0.93 (+2.74%)

VSAT ViaSat
$52.50 /

+0.99 (+1.92%)

SMG Scotts Miracle-Gro
$216.66 /

+3.2 (+1.50%)

SBAC SBA Communications
$254.95 /

-0.31 (-0.12%)

RJF Raymond James
$120.08 /

+3.38 (+2.90%)

PODD Insulet
$264.49 /

+4.2 (+1.61%)

LZB La-Z-Boy
$42.83 /

+0.09 (+0.21%)

LPTX Leap Therapeutics
$2.45 /

+0.09 (+3.81%)

JLL Jones Lang LaSalle
$178.94 /

+4.46 (+2.56%)

IDXX Idexx Laboratories
$527.46 /

+7.49 (+1.44%)

HOLX Hologic
$74.58 /

+2.43 (+3.37%)

FLXN Flexion
$11.48 /

+0.43 (+3.89%)

DXCM DexCom
$401.50 /

+2.25 (+0.56%)

CWST Casella Waste
$58.82 /

+0.68 (+1.17%)

CTT CatchMark Timber
$10.45 /

+0.25 (+2.45%)

CACI CACI
$223.64 /

+2.49 (+1.13%)

BR Broadridge
$144.31 /

+1.75 (+1.23%)

AVT Avnet
$38.99 /

+0.85 (+2.23%)

APLS Apellis
$49.34 /

+1.02 (+2.11%)

ADMA ADMA Biologics
$2.38 /

+0.07 (+3.03%)

  • 21
    Oct
  • 18
    Jun
  • 21
    May
  • 13
    May
SMG Scotts Miracle-Gro
$216.66 /

+3.2 (+1.50%)

SBAC SBA Communications
$254.95 /

-0.31 (-0.12%)

RJF Raymond James
$120.08 /

+3.38 (+2.90%)

HOLX Hologic
$74.58 /

+2.43 (+3.37%)

VSAT ViaSat
$52.50 /

+0.99 (+1.92%)

SMG Scotts Miracle-Gro
$216.66 /

+3.2 (+1.50%)

LZB La-Z-Boy
$42.83 /

+0.09 (+0.21%)

HOLX Hologic
$74.58 /

+2.43 (+3.37%)

DXCM DexCom
$401.50 /

+2.25 (+0.56%)

CWST Casella Waste
$58.82 /

+0.68 (+1.17%)

APLS Apellis
$49.34 /

+1.02 (+2.11%)

WY Weyerhaeuser
$34.81 /

+0.93 (+2.74%)

IDXX Idexx Laboratories
$527.46 /

+7.49 (+1.44%)

HOLX Hologic
$74.58 /

+2.43 (+3.37%)

ADMA ADMA Biologics
$2.38 /

+0.07 (+3.03%)

Friday
Syndicate
SBA Communications files automatic mixed securities shelf  17:22
02/26/21
02/26
17:22
02/26/21
17:22
SBAC

SBA Communications

$255.17 /

-1.43 (-0.56%)

 
ShowHide Related Items >><<
SBAC SBA Communications
$255.17 /

-1.43 (-0.56%)

SBAC SBA Communications
$255.17 /

-1.43 (-0.56%)

02/23/21 Credit Suisse
SBA Communications price target lowered to $277 from $291 at Credit Suisse
02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
SBAC SBA Communications
$255.17 /

-1.43 (-0.56%)

SBAC SBA Communications
$255.17 /

-1.43 (-0.56%)

Over a week ago
Recommendations
SBA Communications price target lowered to $277 from $291 at Credit Suisse » 07:59
02/23/21
02/23
07:59
02/23/21
07:59
SBAC

SBA Communications

$260.09 /

-1.88 (-0.72%)

Credit Suisse analyst…

Credit Suisse analyst Sami Badri lowered the firm's price target on SBA Communications to $277 from $291 and keeps a Neutral rating on the shares. The analyst cites solid results, but weaker than projected organic growth guidance for 2021.

ShowHide Related Items >><<
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

Recommendations
SBA Communications price target raised to $310 from $305 at Barclays » 07:21
02/23/21
02/23
07:21
02/23/21
07:21
SBAC

SBA Communications

$260.09 /

-1.88 (-0.72%)

Barclays analyst Tim Long…

Barclays analyst Tim Long raised the firm's price target on SBA Communications to $310 from $305 and keeps an Overweight rating on the shares following the company's Q4 results. The analyst sees a "strong" setup for fiscal 2021.

ShowHide Related Items >><<
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

Recommendations
SBA Communications price target lowered to $325 from $335 at Deutsche Bank » 06:53
02/23/21
02/23
06:53
02/23/21
06:53
SBAC

SBA Communications

$260.09 /

-1.88 (-0.72%)

Deutsche Bank analyst…

Deutsche Bank analyst Matthew Niknam lowered the firm's price target on SBA Communications to $325 from $335 and keeps a Buy rating on the shares following the company's Q4 results.

ShowHide Related Items >><<
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

SBAC SBA Communications
$260.09 /

-1.88 (-0.72%)

Earnings
SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 » 16:03
02/22/21
02/22
16:03
02/22/21
16:03
SBAC

SBA Communications

$259.97 /

-2 (-0.76%)

Sees FY21 revenue…

Sees FY21 revenue $2.172B-$2.212B, consensus $2.19B.

ShowHide Related Items >><<
SBAC SBA Communications
$259.97 /

-2 (-0.76%)

SBAC SBA Communications
$259.97 /

-2 (-0.76%)

02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
SBAC SBA Communications
$259.97 /

-2 (-0.76%)

SBAC SBA Communications
$259.97 /

-2 (-0.76%)

Earnings
SBA Communications reports Q4 AFFO $2.49, consensus $2.44 » 16:02
02/22/21
02/22
16:02
02/22/21
16:02
SBAC

SBA Communications

$259.55 /

-2.42 (-0.92%)

Reports Q4 revenue $536M,…

Reports Q4 revenue $536M, consensus $528.96M. "We had a very strong finish to 2020, producing material growth in AFFO per share well ahead of plan," commented Jeffrey A. Stoops, President and Chief Executive Officer. "The fourth quarter was our strongest of the year in terms of customer activity, and we continued to execute very well notwithstanding the ongoing impact of Covid-19 to varying degrees across all of our markets. I want to express my continued gratitude to our employees, customers and vendors for their extraordinary efforts during these difficult times. With the CBRS and C-Band auctions now a reality in the US, our recently-announced master agreement with Dish, and important spectrum auctions planned for our international markets over the next two years, we believe we are on the cusp of another increase in operational activity and demand for our infrastructure likely to begin in the second half of 2021 and continue for years thereafter. Together with these favorable business prospects, we find ourselves in a low-interest rate environment with a low cost of capital and abundant sources of financing. As a result, we have stayed fully invested and intend to stay fully invested in our business, repurchasing since our last earnings release 1.8 million shares of our stock and just last week closing on our very exciting transaction with PG&E, among other portfolio growth transactions we have consummated. We are extremely confident and excited about our future, so much so that we have just approved an increase to our quarterly dividend of approximately 25%. While a substantial increase, this dividend on an annual basis represents less than 23% of the midpoint of our AFFO in our 2021 Outlook, leaving us substantial capital for additional investment. We believe we will continue to produce material growth in AFFO per share and, including the dividend, total shareholder return."

ShowHide Related Items >><<
SBAC SBA Communications
$259.55 /

-2.42 (-0.92%)

SBAC SBA Communications
$259.55 /

-2.42 (-0.92%)

02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
SBAC SBA Communications
$259.55 /

-2.42 (-0.92%)

SBAC SBA Communications
$259.55 /

-2.42 (-0.92%)

Hot Stocks
Dish signs master lease agreement with SBA Communications » 08:04
02/22/21
02/22
08:04
02/22/21
08:04
DISH

Dish

$33.67 /

-0.175 (-0.52%)

, SBAC

SBA Communications

$261.93 /

-0.89 (-0.34%)

DISH (DISH) and SBA…

DISH (DISH) and SBA Communications Corporation (SBAC) announced a new long-term master lease agreement providing DISH access to SBA's extensive nationwide portfolio of wireless communication sites. As part of the agreement, DISH will lease towers from SBA, and SBA is expected to deliver a variety of pre-construction functions, ranging from site acquisition to regulatory and compliance services. "With experience spanning more than thirty years, SBA brings a valuable team and portfolio to our infrastructure mix," said Dave Mayo, DISH Executive Vice President of Network Development. "This agreement provides DISH with access to key real estate that will help advance our rapid 5G network deployment across the U.S."

ShowHide Related Items >><<
SBAC SBA Communications
$261.93 /

-0.89 (-0.34%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

12/04/20 Guggenheim
Dish downgraded to Neutral from Buy at Guggenheim
11/18/20 Deutsche Bank
Dish price target lowered to $65 from $69 at Deutsche Bank
11/12/20 Raymond James
Dish price target raised to $58 from $50 at Raymond James
07/20/20 Credit Suisse
F5 Networks price target raised to $170 from $151 at Credit Suisse
SBAC SBA Communications
$261.93 /

-0.89 (-0.34%)

02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
02/08/21 JPMorgan
SBA Communications downgraded to Neutral from Overweight at JPMorgan
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Credit Suisse
SBA Communications downgraded to Neutral from Outperform at Credit Suisse
SBAC SBA Communications
$261.93 /

-0.89 (-0.34%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

SBAC SBA Communications
$261.93 /

-0.89 (-0.34%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

DISH Dish
$33.67 /

-0.175 (-0.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.